$OZMPKscience
GLP-1 drugs reduce US obesity rate below 30% by 2030
Ozempic, Wegovy, and the next generation of weight loss drugs are genuinely unprecedented. If adoption scales the way early data suggests, the public health impact will be the biggest medical story of the decade.
Resolution: CDC NHANES data shows adult obesity prevalence below 30% in the US
$0.1000
per share
Market Cap
$0.00
Total Shares
0
Volume
$0.00
Creator
@foretell
Validation Status
🌱Listed— Just launched○ 1 confirmed milestone
○ $1,000 market cap
○ 5 holders
$10,000 more in market cap unlocks a real funding campaign.
See campaigns →$0.1000+0.00%
Loading chart...
0 trades · 0 candles
🏁 Milestones
No milestones yet. The creator can post progress updates here.